Compare CleanSpark Inc (CLSK) vs Neurocrine Biosciences Inc (NBIX) Price & Performance

CleanSpark IncTrade

Neurocrine Biosciences IncTrade

Price performance (Past 24H)

Key statistics

CleanSpark Inc vs Neurocrine Biosciences Inc — how do they compare? CleanSpark Inc trades at $12.12 (market cap $2.96B), while Neurocrine Biosciences Inc trades at $158.2 (market cap $16.46B). The key difference: Neurocrine Biosciences Inc is far larger — about 5.6× CleanSpark Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, CleanSpark Inc nearer its low. Which is the better fit depends on your goals.

	CLSK	NBIX
Market Cap	$2.96B	$16.46B
Sector	Technology	Health
52-Week High	$23.20	$185.50
52-Week Low	$8.18	$123.10
Enterprise Value	$3.95B	$16.48B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CLSK

Bitcoin miners' stocks drop 5-6% amid Strategy's Bitcoin and stock sales, weighing on crypto sentiment.24/7 Wall Street · 2 days agoBearish View details →

NBIX

INGREZZA shows significant quality of life and movement improvements in tardive dyskinesia patients after 24 weeks.PRNewsWire · 5 hours agoBullish View details →

About CleanSpark Inc

CleanSpark is a leading Bitcoin mining company that operates high-density data centers. It focuses on using sustainable energy to power its mining fleet and provides digital infrastructure for the blockchain ecosystem.

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.